Evidence map›Paper›PMID 30576368›Full record

ArticlePLoS pathogens2018

Heme sensing and detoxification by HatRT contributes to pathogenesis during Clostridium difficile infection.

Reece J Knippel, Joseph P Zackular, Jessica L Moore, Arianna I Celis, Andy Weiss, M Kay Washington, Jennifer L DuBois, Richard M Caprioli, Eric P Skaar

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Microbiology (Reading, England) · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Reece J KnippelDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States of America.ORCID 0000-0002-3129-5468
Joseph P ZackularDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States of America.ORCID 0000-0002-3228-3055
Jessica L MooreDepartment of Biochemistry, Vanderbilt University, Nashville, TN, United States of America.
Arianna I CelisDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT, United States of America.
Andy WeissDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States of America.
M Kay WashingtonDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States of America.
Jennifer L DuBoisDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT, United States of America.
Richard M CaprioliDepartment of Chemistry, Vanderbilt University, Nashville, TN, United States of America.
Eric P SkaarDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States of America.ORCID 0000-0001-5094-8105
Vanderbilt University Medical Center · USMontana State University · USVanderbilt University · US

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Training (pp 214-245)P41GM103391 · NIGMS · VANDERBILT UNIVERSITY · PI REYZER, MICHELLE L · 2012 to 2020
$17.7M
TRAINING IN GASTROENTEROLOGYT32DK007673 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 1992 to 2026
$8.4M
Chemistry-Biology Interface Training GrantT32GM065086 · NIGMS · VANDERBILT UNIVERSITY · PI BACHMANN, BRIAN O, SULIKOWSKI, GARY ALLEN · 2002 to 2022
$7.0M
Pathobiology of heme inducible transporters in Gram positive pathogensR01AI073843 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SKAAR, ERIC P · 2009 to 2025
$5.9M
MOLECULAR PARASITOLOGY TRAINING PROGRAMT32AI007281 · NIAID · MEHARRY MEDICAL COLLEGE · PI NDE, PIUS N · 1985 to 2025
$3.2M
Understanding the diverse biochemistry of the chlorite dismutase family: from O2 to hemeR01GM090260 · NIGMS · UNIVERSITY OF NOTRE DAME · PI DUBOIS, JENNIFER L · 2009 to 2018
$2.7M
Understanding the Contributions of Commensal Bacteria to Human Fe MetabolismR21DK114607 · NIDDK · MONTANA STATE UNIVERSITY - BOZEMAN · PI DUBOIS, JENNIFER L, WALK, SETH T · 2017 to 2018
$390k
The impact of dietary metals on the gut microbiome and Clostridium difficile infectionF32AI120553 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ZACKULAR, JOSEPH PAUL · 2015 to 2017
$109k
NIAID NIH HHS F32 AI120553NIAID NIH HHS R01 AI073843NIAID NIH HHS T32 AI007281NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R21 DK114607NIDDK NIH HHS T32 DK007673NIGMS NIH HHS P41 GM103391NIGMS NIH HHS R01 GM090260NIGMS NIH HHS T32 GM065086
6 · The paper itself

Abstract

Clostridium difficile is a Gram-positive, spore-forming anaerobic bacterium that infects the colon, causing symptoms ranging from infectious diarrhea to fulminant colitis. In the last decade, the number of C. difficile infections has dramatically risen, making it the leading cause of reported hospital acquired infection in the United States. Bacterial toxins produced during C. difficile infection (CDI) damage host epithelial cells, releasing erythrocytes and heme into the gastrointestinal lumen. The reactive nature of heme can lead to toxicity through membrane disruption, membrane protein and lipid oxidation, and DNA damage. Here we demonstrate that C. difficile detoxifies excess heme to achieve full virulence within the gastrointestinal lumen during infection, and that this detoxification occurs through the heme-responsive expression of the heme activated transporter system (HatRT). Heme-dependent transcriptional activation of hatRT was discovered through an RNA-sequencing analysis of C. difficile grown in the presence of a sub-toxic concentration of heme. HatRT is comprised of a TetR family transcriptional regulator (hatR) and a major facilitator superfamily transporter (hatT). Strains inactivated for hatR or hatT are more sensitive to heme toxicity than wild-type. HatR binds heme, which relieves the repression of the hatRT operon, whereas HatT functions as a heme efflux pump. In a murine model of CDI, a strain inactivated for hatT displayed lower pathogenicity in a toxin-independent manner. Taken together, these data suggest that HatR senses intracellular heme concentrations leading to increased expression of the hatRT operon and subsequent heme efflux by HatT during infection. These results describe a mechanism employed by C. difficile to relieve heme toxicity within the host, and set the stage for the development of therapeutic interventions to target this bacterial-specific system.

Indexed as

AnimalsBacterial ProteinsClostridioides difficileClostridium InfectionsGenes, BacterialHemeMaleMiceMice, Inbred C57BLOperonVirulenceBacterial ProteinsHeme

Identifiers

PMID30576368
PMCPMC6303022
OpenAlexW2906226216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.